Cencora Inc. logo

Cencora Inc.

COR | NYSE
Chart Builder DCF Calculator
$308.78
-$0.63 (-0.20%)
At close: Sep 18, 2026, 4:00 PM ET
$307.01
-$1.77 (-0.57%)
Pre-market: Sep 21, 2026, 7:17 AM ET

Company Profile

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Key Executives

Name Position
Robert Mauch President, Chief Executive Officer & Director
Elizabeth S. Campbell Executive Vice President & Chief Legal Officer
Eva C. Boratto Executive Vice President & Chief Financial Officer
Bennett S. Murphy Senior VP Of Investor Relations & Enterprise Productivity and Treasury
François Mandeville Executive Vice President and Chief Strategy and M&A Officer
James F. Cleary Jr. Advisor
Juan Guerra EVP & President of International Business Group
Lazarus Krikorian Senior Vice President, Chief Accounting Officer & Corporate Controller
Pawan Singh Verma Executive Vice President and Chief Data & Information Officer
Richard Tremonte EVP and President of U.S. Pharmaceuticals & Animal Health
Samantha L. Hammock Executive Vice President & Chief Human Resources Officer
Silvana Battaglia Advisor

Latest SEC Filings

Date Type Title
Sep 02, 2026 4 Filing
Aug 25, 2026 4 Filing
Aug 14, 2026 8-K Current Report
Aug 12, 2026 8-K Current Report
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Aug 05, 2026 8-K Current Report
Aug 04, 2026 4 Filing
Aug 04, 2026 4 Filing
Aug 04, 2026 4 Filing
View All SEC Filings
Cencora Inc.
Cencora Inc. logo
Country United States
IPO Date Apr 3, 1995
Industry Medical - Distribution
Sector Healthcare
Employees 49,000
CEO Robert Mauch

Contact Details

1 West First Avenue Conshohocken, Pennsylvania 19428-1800 United States

Stock Details

Ticker Symbol COR
Exchange NYSE
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001140859
CUSIP Number 03073E105
ISIN Number US03073E1055
SIC Code 5122

© 2026 bestshares.com. All rights reserved.